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Abstract: Pathological changes of nasosinus occur often in subjects with bronchial
asthma. Coexisting nasosinus lesion may affect pathophysiology of lower respiratory
tract in asthmatics. The extent of nasal and sinus lesion was quantified in 17 patients
with bronchial asthma, and their relationships to atopic status, asthma severity and
bronchial· hyperresponsiveness were evaluated in this study. Opacification degree of
maxillary sinuses and nasal mucosa thickening were quantified using CT scans. The
opacification degree was evaluated as (total opacification area)/(total maxillary
sinus area). Although the opacification degree of maxillary sinuses in atopic patients
showed no significant difference compared with that in non-atopic patients, maximum
nasal mucosa thickening in atopic patients had a significant difference compared with
that in non-atopic patients (p=0.028). In severe asthmatics, the opacification degree of
maxillary sinuses was significantly more prominent compared with those in moderate
and mi ld asthmatics (p=0.0005, p=0.036, respectively). Significantly marked nasal
mucosa thickening was recognized in mild asthmatics compared with that in moderate
asthmatics (p=0.0462). Regarding bronchial hyperresponsiveness, a significant correla-
tion between Dmin and the opacification degree of maxi lIary sinuses was observed
(rs= -0.551, p=0.0276). Nasal mucosa thickening had no correlation with bronchial
hyperresponsiveness. The results suggest that sinusitis may affect bronchial hyper-
responsiveness and asthma severity. Treatment of sinusitis may lead to improvement
of asthma symptoms.
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The association of asthma with nasosinus
disease has been recognized more than a
century ago. Since 1980, several studies have
documented that severe asthma ,improved
after coexisting sinusitis was effectively
treated either medically or surgically',2l. These
findings suggest coexisting chronic sinusitis is
a precipitating factor for bronchial asthma.
However, the influence of nasosinus disease
on pathogenesis of asthma is poorly under·
stood. Some investigators have shown the
reduction in asthma symptoms and improve-
ment in bronchial hyperresponsiveness during
pollen seasons with the use of intranasal
corticoids4,5). These data suggest that there
may be a relationship in inflammatory events
between the upper and lower airways, and
that nasosinus disease may affect asthma
exacerbation.
In the present study, the opacification of
maxillary sinuses and nasal mucosa thicken-
ing were quantified in the patients with
bronchial asthma, and the correlation be-
tween the extent of nasosinus lesion and
bronchial hyperresponsiveness was evaluated.
Methods
Subjects characteristics
The subjects in this study were 17 patients
with asthma 03 females and 4 males, mean
age 51.6 years ranged from 25 to 73 years)
(Table 1). Asthma was defined according to
the definition of the Guidelines for the Diag-
nosis and Management of 'Asthma3). All
subjects had experiences of episodic symptoms
of wheeze, coughing, and dyspnea, and were
being treated with inhaled jj -adrenergic ago-
nists for symptomatic relief. None of sub-
jects had received surgical treatments of
sinusitis. Clinical features were evaluated by
asthma type, disease severity and bronchial
hyperresponsiveness. Serum IgE level and IgE
antibodies against common aeroallergens were
examined by radioimmunosorbent test (RIST)
and radioallergosorbent test (RAST), respect-
ively. Patients with positive IgE RAST scores
and/or IgE level more than 250 IU/ml were
assessed as atopic. Disease severity was
evaluated according to the criteria for
asthma severity of the Guidelines for the
Diagnosis and Management of Asthma3). Ten
Table. 1 Clinical and laboratory data in 17 asthmatics
Subject Sex/Age atopy Pulmonary functionNo. (years)
FVC FVC,% FEV1 FEV1,% FEV1NC
liters predicted liters predicted %
1 F/25 + 3.17 105.3 2.60 88.1 82.0
2 M/58 3.20 91.2 2.03 72.8 67.2
3 F/51 2.80 107.6 2.33 101.9 83.2
4 M/32 + 5.16 125.5 3.39 88.5 65.7
5 F/62 + 2.40 101.3 1.55 82.9 64.6
6 M/38 + 4.48 109.0 2.56 . 67.4 57.1
7 F/61 2.88 127.0 2.22 131.4 77.1
8 F/54 3.52 141.8 2.66 129.5 75.6
9 F/55 + 3.00 118.1 2.51 106.7 83.7
10 M/45 + 2.35 94.4 1.79 86.9 76.2
11 F/66 + 2.37 63.9 1.73 54.7 73.0
12 F/73 1.45 64.7 0.79 48.2 54.5
13 F/64 + 1.76 84.6 1.16 85.9 65.9
14 F/26 2.19 99.3 1.53 97.0 69.9
15 F/47 + 2.67 87.3 2.50 82.5 93.6
16 F/42 + 4.02 130.5 2.20 80.6 57.4
17 F/63 1.76 76.9 1.14 66.3 64.8
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patients were regarded as atopic, and 7 cases
were non-atopic. Regarding asthma severity,
4 subjects had mild, 10 had moderate and 3
had severe asthma.
Evaluation of bronchial hyperresponsiveness
Bronchial hyperresponsiveness to inhaled
methacholine was measured with a device
(Astograph-TCK-6100H, Chest, Tokyo, Japan)
that displays a respiratory resistance (Rrs)
dose-response curve measured by the forced
oscillation method during tidal breathing
with continuos inhalation of aerosolized
methacholine solution. Dmin (the minimum
dose of methacholine) was obtained as the
cumulative dose at the point where respira-
tory conductance (reciprocal of Rrs) starts
to decrease linearly.
CT evaluation
Computed tomographic (CT) scans of na-
sal cavity and maxillary sinuses were per-
formed in all patients with a Toshiba Xpeed
(Toshiba medical, Tokyo, Japan). All sub-
jects had treated with antibiotics and decon-
gestants for 1 week before CT scans. The
eight contiguous 5.0mm horizontal scans were
obtained from the level of the 2.0cm below
nasal-meatal lines. Scans were performed at
120kVp and 300mA without contrast. The CT
scans were photographed at a window level
of 20 HU and a window width of 350 HU.
Slices viewing, maxillary sinuses were selected
from eight scans. Four to seven slices view-
ing maxillary sinuses were obtained. These
images were transferred to a Macintosh
computer(Apple Computers, Cupertino, Calif.,
USA)with imagescanner (model ES - 8000,
EPSON, Tokyo, Japan). To obtain absolute
measurements of maximum thickening of na-
sal mucosa and opacification degree of,,!naxil-
lary sinuses, the measurements were normal-
ized using the scale on the CT ,image.
Maxillary smus area (M) m mnl and
opacification area (0) in mnl in each VieW
were determined. If maxillary sinus wall
discontinued for a short distance, maxillary
wall was assumed to continue linearly. In the
slice of long discontinuation of the maxillary
wall, the slice was excluded. The opaci-
fication degree of maxillary sinuses was
calculated as (total a/total M) x 100. The
analyses were performed using the public
domain NIH image program (developed at the
U. S. National Institutes of Health and avail-
able on the Internet at http : / / rsb. info.
nih.gov/ nihimage/) .
Data analysis
All data were presented as means±SD. The
unpaired t test was used to examine the
difference in atopic status and in asthma
severity. Spearman's correlation coefficient
by ranks was used to examine the relation-
ships between the nasosinus lesion and bron-
chial hyperresponsiveness (Dmin). A p value
of<0.05 was regarded as significant.
Results
The opacification degree of, maxillary, SI-
nuses was 11.4±14.3% in atopic, and 10.9±
6.23% in non-atopic patients. There were no
significant differences between the two types
(p=0.93). Significant differences were ob-
served in nasal mucosa thickening between
atopic (8.53 ± 1.36mm) and non-atopic sub-
jects (7.17±1.17mm) (p=0.028) (Fig. 1).
Maxillary mucosal lesions were different
according to disease severity. The opaci-
fication degree of maxillary sinuses was more
,extensive in subjects with severe asthma than
other two groups (7.2±8.6% in mild asthma
group, 7.1±5.4% in moderate asthma group
and 30.0 ± 12.3% in severe ,as,thma group).
The difference in opacification degree was
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Fig. 1. Correlation between atopic status and the opacification degree of maxillary sinuses
(A), and between atopic status and nasal mucosal thickening (B). There was a
siginificant difference of nasal mucosa thickening between atopic and non-atopic
subjects.
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Fig. 2. Correlation between asthma severity and the opacification degree of maxillary sinuses
(A) and between asthma severity and nasal mucosa thickening (B). There was a
siginificant difference of the opacification degree of maxillary sinuses between severe
and moderate asthmatics (a; p=O.0005), andbetween severe and mild asthmatics (b;
p=O.036). There was a siginificant difference of nasal mucosa thickening between
moderate and mild asthmatics (c; P=O.0462).
Bronchial hyperresponsiveness and nasosinus disease in asthmatics 32
significant between mild asthma group and
severe asthma group (p=0.034), and between
moderate asthma group and severe asthma
group (p=0.0005). (Fig. 2A). Nasal mucosa
thickening was 9.0±1.5mm in subjects with
mild asthma, 7.4±1.1mm in those with mod-
erate asthma, and 8.3±1.1mm in those with
severe asthma. Significant differences were
observed between moderate and mild
asthmagroup (p=0.046) (Fig. 2B).
Regarding bronchial hyperresponsiveness,
the opacification degree of maxillary sinuses
showed significant negative correlation with
Dmin (rs= -0.551, p=0.0276). On the other
hand, nasal mucosa thickening showed no
significant correlation with Dmin (rs=0.09,
p=0.72) (Fig.3).
Discussion
It is often suggested that important rela-
tionship may exist between upper and lower
airways. In patients with viral upper respi-
ratory tract infections, bronchial hyper-
responsiveness may be increased 6) • Improve-
ment in asthma scores were reported after
treatment with intranasal glucosteroids in
patients with allergic rhinitis and concurrent
asthma, but not after treatment with intran-
asal cromolyn 7). Furthermore, recent studies
revealed that patients with chronic sinusitis
had bronchial hyperresponsiveness. Bucca et
al. has demonstrated that some patients with
chronic sinusitis had bronchial hyperrespon-
siveness during sinusitis exacerbation. Some
of their patients had cough and wheeze,
suggesting the coexistence of lower airway
disease8). Okayama and colleagues have show-
ed .that patients with chronic sinusitis who
had normal lung functions without any pul-
monary symptoms had bronchial hyperrespon-
siveness and bronchial hyperresponsiveness
significantly decreased after the surgical
50 A 50 B
45 rs=-O.551 45 rs=O.09 •40 p=O.0276 40 p=O.72
35 35-
:2' 30 :g 30-e::
::::I ::::I
~25 ~ 25-
E 20 E 20-
0 0
15 15-
10 10- •
5 5- • •0 0 -- --
-
- '--10 5 10 15 20 25 30 35 40 45 0 2 4 6 8 10 12
opacification degree nasal mucosa thickening (mm)
ofmaxillarysinues (%)
Fig. 3. Correlation bronchial hyperresponsiveness and nasosinus lesion. There was a siginificant
correlation between Dmin and opacification degree of maxillary sinuses (a). Nasal
mucosa thickening showed no correlation with Dmin.
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treatment of chronic sinusitis9). These data
suggest that sinusitis may affect bronchial
hyperresponsiveness in subjects with sinusitis.
In subjects with bronchial asthma, we showed
a significant negative correlation between the
extent of maxillary sinus lesions and bron-
chial hyperresponsiveness in this study. Our
data have shown that asthmatics with
marked sinusitis might reveal increased bron-
chial hyperresponsiveness. And significant
marked lesion in maxillary sinuses was ob-
served in subjects with severe asthma in our
study. This result suggest that sinusitis may
have influence on exacerbation of asthma
severity.
On the other hand, nasal mucosal thicken-
ing have shown no correlation with bronchial
hyperresponsiveness, and had marked lesion in
mild asthmatics in our study. Our results
suggest that nasal mucosa disease is not
likely to affect the pathophysiology of bron-
chial asthma. However, several studies have
shown that treatments for allergic rhinitis
affected asthma symptoms10, 11). Watson and
colleagues reported that asthma symptoms
and bronchial hyperresponsiveness tometh-
acholine improved significantly after intran-
asal beclomethasone dipropionate for peren-
nial rhinitis. As an adjunct to the study,
they performed a radiolabeled deposition
study of the beclomethasone aerosol and
found that less than 2% of the drug was
deposited into the chest areao. These studies
indicate that nasal mucosa lesion may affect
asthma pathophysiology. Although nasal
mucosa' thick~ning had no correlation with
bronchial hyperresponsiveness in our results,
6ther factors, such as nasal discharge, may
affect bronchial hyperresponsiveness. We
evaluated the maximum nasal mucosa thick-
ening as a factor showing severity of nasal
mucosa lesion. Other assessments of nasal
mucosa lesion might have been needed to
evaluate the relationship with bronchial
hyperresponsiveness.
The mechanism that upper respiratory
lesions affect lower respiratory lesions is
unknown by now. Several mechanisms were
proposed. The inflammatory cells or media-
tors in post-nasal discharge aspirating into
lower respiratory tract could exacerbate
bronchial hyperresponsiveness. In a rabbit
model, increased bronchial hyperrespon-
siveness associated with sinusitis was demon-
strated 12J. Another proposed mechanism is the
increased oral inhalation of cold and dry air
caused by nasal obstruction. However, this
mechanism can not fully explain the present
findings that the extent of sinus lesion have
relationship with bronchial hyperrespon-
siveness, and nasal mucosa thickening had no
correlation with bronchial hyperrespon-
Slveness. Another mechanism IS a na-
sopulmonaly reflex. The cholinergic nervous
system irritated by sinus or nasal inflamma-
tory change induce a secondary increase in
pulmonary airway resistance. But mechanism
that nasopulmonary reflex induce bronchial
hyperresponsiveness is not fully explained.
Thus, aspiration of post-nasal discharge is
most likely to affect lower bronchial condi-
tion, But further studies are needed to clarify
the mechanism that upper respiratory lesion
affects lower respiratory lesion.
In conclusion, this study suggests that
sinusitis may affect on asthma severity and
bronchial hyperresponsiveness. Therefore, ther-
apy for coexisting sinusitis is important In
subjects with bronchial asthma.
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鼻腔 ･副鼻腔疾患はしばしば気管支鳴息症例に
合併が認められ,鳴息症例の下気道病態に影響を
及ぼしている可能性が考えられる｡今回,気管支
鳴息17例において,CTを用いて上顎洞の不透明
化率 ･鼻腔粘膜肥厚を計測し,アトピー 性の有無,
鳴息の重症度,気道過敏性との関係を検討した｡
上顎洞不透明化率は全上顎洞面積の総計に対する
不透明化領域面積総計として計算を行った｡上顎
洞不透明化率はアトピー性の有無で差は認められ
なかったが,鼻腔粘膜はアトピー性鳴息症例で有
意に肥厚していた｡重症気管支鳴息における上顎
洞不透明化率は,中等症および軽症鳴息症例に比
べ有意に高値であった｡鼻腔粘膜肥厚は中等症鳴
息症例に比べ,軽症症例で有意に肥厚していた｡
気道過敏性 (Dmin)は上顎洞不透明化率とのあ
いだに弱い負の相関が認められた (rs--0.551,
p-0.0276).鼻粘膜肥厚と気道過敏性は相関が認
められなかった｡今回の結果から副鼻腔病変が気
道過敏性 ･鳴息重症度に影響を及ぼしている可能
性が考えられ.副鼻腔疾患の治療により鳴息症状
の改善に繋がる可能性が考えられた｡
索引用語 :気管支鳴息,副鼻腔炎,CT所見,気
道過敏性
